Re: [RESULT] Cilium approved for Incubation

Michael Branan

Congrats Cilium team!  










Michael Branan
Principal Solutions Architect
t: (410) 590-2008 | m: (410) 608‑2208

From: cncf-toc@... <cncf-toc@...> on behalf of Tina Tsou via <>
Date: Wednesday, October 13, 2021 at 11:07 AM
To: leecalcote@... <leecalcote@...>, alexis richardson <alexis@...>
Cc: Amye Scavarda Perrin <ascavarda@...>, CNCF TOC <cncf-toc@...>
Subject: Re: [cncf-toc] [RESULT] Cilium approved for Incubation

CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.


Dear Cilium team,


Bravo! Well done.



Thank you,



From: cncf-toc@... <cncf-toc@...> On Behalf Of Lee Calcote via
Sent: Wednesday, October 13, 2021 10:23 AM
To: alexis richardson <alexis@...>
Cc: Amye Scavarda Perrin <ascavarda@...>; CNCF TOC <cncf-toc@...>
Subject: Re: [cncf-toc] [RESULT] Cilium approved for Incubation


Pretty awesome. :)


On Oct 13, 2021, at 11:55 AM, alexis richardson <alexis@...> wrote:




On Wed, 13 Oct 2021, 17:53 Amye Scavarda Perrin, <ascavarda@...> wrote:

Cilium has been approved at the incubation level.

Justin Cormack:
Alena Prokharchyk:
Erin Boyd:
Liz Rice:
Davanum Srinivas:
Lei Zhang:
Ricardo Rocha:
Sheng Liang:
Dave Zolotusky:
Saad Ali:

+1 NB
Moh Ahmed:
Timothy Horner:
Jim St Leger:
Chandler Hoisington:
Somik Behera:
Stephen Augustus:
Chris Short:
Tamal Saha:
Lee Calcote:
Joe Searcy:
Archy K:
Leonardo Di Donato:
Mark Carter:
Kiran Mova:
Yusuf Hadiwinata Sutandar:
Bing Lien:
Pengfei Ni:
Anil Vishnoi:
Matt Klein:
Phil Estes:
Andy Randall:
Joseph Irving:
Roberth Strand:
Ricardo Aravena:
Bartłomiej Płotka:
Philippe Robin:
Franco Geraci:
Bob Killen:
Kevin Ryan:
Golfen Guo:
Rajesh K:
Tina Tsou:  




IMPORTANT NOTICE: The contents of this email and any attachments are confidential and may also be privileged. If you are not the intended recipient, please notify the sender immediately and do not disclose the contents to any other person, use it for any purpose, or store or copy the information in any medium. Thank you.

Join to automatically receive all group messages.